Back to Search
FRANK BOCK, D.O.
D.O.
Hospice and Palliative Medicine (Internal Medicine) Physician
NPI: 1467430975IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine Physician
Family Medicine
Code: 207Q00000X
32084(MN)
Hospice and Palliative Medicine (Internal Medicine) PhysicianPrimary
Internal Medicine — Hospice and Palliative Medicine
Code: 207RH0002X
32084(MN)
CMS Specialties
PrimaryHOSPICE/PALLIATIVE CARE
Additional
FAMILY PRACTICE
Education
OTHER
Class of 1987
Research & Publications (20)
Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization.
PMID 19415316·Graefes Arch Clin Exp Ophthalmol·2009
8-other
[Topical inhibition of angiogenesis at the cornea. Safety and efficacy].
PMID 19396447·Ophthalmologe·2009
6-review
Caspase-2 activation in the absence of PIDDosome formation.
PMID 19364921·J Cell Biol·2009
7-preclinical
Transient postoperative vascular endothelial growth factor (VEGF)-neutralisation improves graft survival in corneas with partly regressed inflammatory neovascularisation.
PMID 19224901·Br J Ophthalmol·2009
7-preclinical
GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial.
PMID 19643487·Ophthalmology·2009
3-trial
Safety profile of topical VEGF neutralization at the cornea.
PMID 19151400·Invest Ophthalmol Vis Sci·2009
7-preclinical
Tumour-associated lymphangiogenesis in conjunctival malignant melanoma.
PMID 19628489·Br J Ophthalmol·2009
8-other
Bevacizumab (Avastin) eye drops inhibit corneal neovascularization.
PMID 17934753·Graefes Arch Clin Exp Ophthalmol·2008
8-other
Corneal (lymph)angiogenesis--from bedside to bench and back: a tribute to Judah Folkman.
PMID 19093792·Lymphat Res Biol·2008
6-review
Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts.
PMID 18789928·Exp Eye Res·2008
7-preclinical
Age-related changes in murine limbal lymphatic vessels and corneal lymphangiogenesis.
PMID 18755186·Exp Eye Res·2008
7-preclinical
Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation.
PMID 18436817·Invest Ophthalmol Vis Sci·2008
7-preclinical
Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation.
PMID 18195221·Arch Ophthalmol·2008
7-preclinical
Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation.
PMID 17909835·Graefes Arch Clin Exp Ophthalmol·2008
7-preclinical
Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade.
PMID 17591980·Am J Pathol·2007
7-preclinical
Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis.
PMID 17525183·Invest Ophthalmol Vis Sci·2007
7-preclinical
[Inhibition of angiogenesis in the anterior chamber of the eye].
PMID 17372736·Ophthalmologe·2007
1-meta
Laterality of interhemispheric inhibition depends on handedness.
PMID 17287992·Exp Brain Res·2007
8-other
Biodegradation rates of 2-methylisoborneol (MIB) and geosmin through sand filters and in bioreactors.
PMID 17005238·Chemosphere·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 1ST ST SW
ROCHESTER, MN 55905 - Phone
- (507) 284-2511
Quick Facts
- NPI
- 1467430975
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile